Search Results
Sort by:
Filter 0
Sort by
23 April 2022 - P0596
In vitro antibacterial activity of cefiderocol against a multi-national collection of Stenotrophomonas maltophilia and Burkholderia spp.: SIDERO-WT-2014-2019
23 April 2022 - P0579
Cefiderocol susceptibility against molecularly characterised carbapenemase-producing Acinetobacter baumannii complex in North America and Europe between 2014 and 2019: SIDERO-WT-2014-2019 studies
23 April 2022 - P0581
Cefiderocol susceptibility against molecularly characterised carbapenemase-producing Pseudomonas aeruginosa in North America and Europe between 2014 and 2019: SIDERO-WT-2014-2019 studies
23 April 2022 - P0556
Cefiderocol susceptibility against molecularly characterised carbapenemase-producing Enterobacterales in North America and Europe between 2014 and 2019: SIDERO-WT-2014-2019 studies
23 April 2022 - P1391
Efficacy of cefiderocol in patients with nosocomial pneumonia and complicated urinary tract infections caused by Enterobacterales and carbapenem-resistant Enterobacterales (CREs) from three randomised clinical trials
15 April 2019 - P1803
Distribution of Gram-negative pathogens by infection site among hospitalised adult patients in United States hospitals between 2010 and 2015
15 April 2019 - P1855
In vitro antibacterial activity of cefiderocol against an international collection of carbapenem-non-susceptible Gram-negative bacteria isolated from respiratory, blood, skin/soft tissue and urinary sources of infection: SIDERO-WT-2014-2016
15 April 2019 - P1851
Cefiderocol in vitro activity against Gram-negative clinical isolates collected in Europe: result from SIDERO-CR-2014/2016
15 April 2019 - P1852
Cefiderocol in vitro activity against Gram-negative clinical isolates collected in Europe: result from three SIDERO-WT surveillance studies between 2014-2017
15 April 2019 - P1854
In vitro and in vivo activity of cefiderocol against Burkholderia cepacia complex clinical isolates
15 April 2019 - P1853
Cefiderocol susceptibility and geographical analysis against globally isolated meropenem non-susceptible Gram-negative bacteria containing serine- and metallo-carbapenemase gene
14 April 2019 - P0911
Prevalence and treatment of Stenotrophomonas maltophilia among adult patients in United States hospitals between 2010 and 2015
24 April 2017 - P1313
The in-vitro activity of cefiderocol, a novel siderophore cephalosporin, against a global collection of Stenotrophomonas maltophilia
24 April 2017 - P1314
Surveillance of cefiderocol in-vitro activity against Gram-negative clinical isolates collected in Europe: SIDERO-WT-2014
24 April 2017 - P1316
In-vitro activity of cefiderocole against globally collected carbapenem-resistant Gram-negative bacteria including isolates resistant to ceftazidime/avibactam, ceftolozane/tazobactam and colistin: SIDERO-CR-2014/2016 study
24 April 2017 - OS0750
Mode of action of cefiderocol, a novel siderophore cephalosporin, active against highly resistant Gram-negative bacteria including carbapenem-resistant strains of Enterobacteriaceae and non-fermenting bacteria
22 April 2017 - OS0250D
Cefiderocol Compared with Imipenem/Cirastatin in the Treatment of Adults with Complicated Urinary Tract Infections with or without Pyelonephritis or Acute Uncomplicated Pyelonephritis: Results from a Multicenter, Double-blind, Randomized Study
Loading ...
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.